<DOC>
	<DOCNO>NCT01313104</DOCNO>
	<brief_summary>This clinical trial study colposcopy high resolution anoscopy screen anal dysplasia patient cervical , vaginal , vulvar dysplasia cancer . Screening may help doctor find cancer cell early plan well treatment cancer</brief_summary>
	<brief_title>Colposcopy High Resolution Anoscopy Screening For Anal Dysplasia Patients With Cervical , Vaginal , Vulvar Dysplasia Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . To evaluate risk anal dysplasia woman cervical vulvar dysplasia . OUTLINE : Patients undergo colposcopy cervical Papanicolaou test Human papillomavirus ( HPV ) test follow anal Papanicolaou test high resolution anoscopy . Patients dysplastic anal lesion undergo repeat anoscopy 3 , 9 , 15 , 24 month . Patients normal anoscopy follow 1 2 year .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<criteria>Histological confirmation cervical , vaginal vulvar intraepithelial neoplasia cancer include Individuals treat prior radiation therapy and/or chemotherapy allow Women highgrade dysplasia ( carcinoma situ ) eligible , regardless dysplasia free interval HIVpositive ( Human Immunodeficiency Virus ) HIVnegative woman enrol ; HIV test perform part study Women able consent exclude</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>